Edition:
United States

Guerbet SA (GRBT.PA)

GRBT.PA on Paris Stock Exchange

49.55EUR
17 May 2019
Change (% chg)

€1.35 (+2.80%)
Prev Close
€48.20
Open
€49.90
Day's High
€50.30
Day's Low
€49.05
Volume
2,382
Avg. Vol
3,736
52-wk High
€65.50
52-wk Low
€46.95

Latest Key Developments (Source: Significant Developments)

Guerbet Q1 Revenue Up At 195.4 Million Euros At Constant Exchange Rates
Thursday, 18 Apr 2019 12:10pm EDT 

April 18 (Reuters) - GUERBET SA ::Q1 REVENUE EUR 195.4 MILLION AT CONSTANT EXCHANGE RATE VERSUS EUR 183.2 MILLION YEAR AGO.OBJECTIVES UNCHANGED.IN 2019 EXPECTS MODERATE GROWTH IN SALES.  Full Article

Guerbet Sees Moderate Growth In Sales In 2019
Tuesday, 26 Mar 2019 01:27pm EDT 

March 26 (Reuters) - GUERBET SA ::FY NET INCOME EUR 46.8 MILLION VERSUS EUR 46.2 MILLION YEAR AGO.FY EBITDA EUR 110.6 MILLION VERSUS EUR 130.0 MILLION YEAR AGO.FY REVENUE EUR 789.6 MILLION VERSUS EUR 807.1 MILLION YEAR AGO.PROPOSES DIVIDEND OF EUR 0.85 PER SHARE.SEES MODERATE GROWTH IN SALES IN 2019.SHOULD SEE A SIGNIFICANT IMPROVEMENT IN CASH FLOW IN FY 2019.  Full Article

New Indication Approved For Guerbet’s Lipiodol Ultra Fluid
Tuesday, 11 Sep 2018 01:23pm EDT 

Sept 11 (Reuters) - GUERBET SA ::NEW INDICATION APPROVED FOR GUERBET’S LIPIODOL ULTRA FLUID IN BELGIUM, IRELAND, PORTUGAL, HONG-KONG AND THE PHILIPPINES.LIPIODOL ULTRA FLUID NOW APPROVED FOR CONVENTIONAL TRANS-ARTERIAL CHEMOEMBOLIZATION OF INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA.  Full Article

Guerbet And IBM Watson Health Signs Strategic Partnership For AI In Medical Imaging
Tuesday, 10 Jul 2018 02:30am EDT 

July 10 (Reuters) - GUERBET SA ::REG-GUERBET AND IBM WATSON HEALTH ANNOUNCE STRATEGIC PARTNERSHIP FOR ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING, LIVER.SIGNED EXCLUSIVE JOINT DEVELOPMENT AGREEMENT TO DEVELOP AI SOFTWARE SOLUTION WITH IBM WATSON HEALTH.IBM RESEARCH TEAM WILL ALSO WORK ON DEVELOPMENT OF THE SOLUTIONS LEVERAGING PRIOR RESEARCH INNOVATIONS.  Full Article

Guerbet: FY Revenue At Constant Exchange Rates Increases To 812.4 Million Euros
Thursday, 15 Feb 2018 11:46am EST 

Feb 15 (Reuters) - GUERBET SA ::REG-GUERBET : 2017 REVENUE AT CONSTANT EXCHANGE RATES: €812.4 MILLION; +4.7%.IS ALSO ANNOUNCING ACQUISITION OF ACCURATE MEDICAL THERAPEUTICS.GROUP’S TARGETS FOR 2017 REMAIN UNCHANGED WITH EBITDA EXPECTED TO OUTPACE REVENUE GROWTH RATE.‍​.  Full Article

Guerbet Announces Acquisition Of Accurate Medical Therapeutics
Monday, 8 Jan 2018 11:49am EST 

Jan 8 (Reuters) - GUERBET SA ::ANNOUNCES ACQUISITION OF ACCURATE MEDICAL THERAPEUTICS.TO ACQUIRE 100% OF ACCURATE'S SHARES WITH AN INITIAL PAYMENT OF € 19.5 MILLION AND ADDITIONAL PAYMENTS SPREAD OVER SEVERAL YEARS.TOTAL AMOUNT OF THE ACQUISITION MAY NOT EXCEED 57 MILLION EUROS.OPERATION IS EXPECTED TO START GENERATING REVENUE AT THE END OF 2018 AND TO BE ACCRETIVE AS OF THE 4TH QUARTER OF 2019.ACCURATE WILL RETAIN ITS STRUCTURE IN ISRAEL AND CONTINUE TO BE LED BY ITS CO-FOUNDER AND CEO, ERAN MILLER.  Full Article

Guerbet 9 months revenue up at ‍​601.4 million euros
Wednesday, 25 Oct 2017 11:50am EDT 

Oct 25 (Reuters) - GUERBET SA ::9 MONTHS REVENUE AT CURRENT EXCHANGE RATE EUR ‍​601.4 MILLION VERSUS EUR 568.4 MILLION YEAR AGO.MAINTAINS FY 2017 OBJECTIVES‍​.  Full Article

Guerbet H1 net income up at 23.1 million euros
Tuesday, 26 Sep 2017 11:47am EDT 

Sept 26 (Reuters) - GUERBET SA ::H1 NET INCOME EUR 23.1 MILLION VERSUS EUR 12.1 MILLION YEAR AGO.H1 OPERATING INCOME EUR 40.7 MILLION VERSUS EUR 26.3 MILLION YEAR AGO.SEES 2017 ANNUAL REVENUE GROWTH AT 3 TO 4% WITH EBITDA IN HIGHER GROWTH THAN THE REVENUE GROWTH.  Full Article

Guerbet announces CE mark for Vectorio
Thursday, 14 Sep 2017 12:02pm EDT 

Sept 14 (Reuters) - GUERBET SA :REG-GUERBET ANNOUNCES CE MARK FOR VECTORIO.  Full Article

FDA approves Guerbet’S Dotarem for patients younger than two years‍​
Tuesday, 5 Sep 2017 01:23pm EDT 

Sept 5 (Reuters) - GUERBET SA ::FDA APPROVES GUERBET’S DOTAREM (GADOTERATE MEGLUMINE) FOR PEDIATRIC PATIENTS YOUNGER THAN TWO YEARS‍​.  Full Article

BRIEF-Guerbet: Transition From Temporary Importation To Regular Supply For Lipiodol Injection

* GUERBET LLC USA ANNOUNCED ON MONDAY TRANSITION FROM TEMPORARY IMPORTATION TO REGULAR SUPPLY FOR LIPIODOL (ETHIODIZED OIL) INJECTION; ALSO INTRODUCES NEW GLASS VIAL CONTAINER